Cargando…

Beneficial use of predilution in reducing the amount of anticoagulation and the occurrence of bleeding during CRRT in critically ill patients: a prospective randomized study

Detalles Bibliográficos
Autores principales:	Honoré, PM, Wittebole, X, Lemaire, M, Pirenne, B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 1998
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301373/ http://dx.doi.org/10.1186/cc261

Ejemplares similares

Evaluation of the predilution technique in reducing the occurrence of bleeding during continuous venovenous haemofiltration in critically ill patients. Efficacy of predilution in reducing the amount of anticoagulation during CVVH
por: Honore, PM, et al.
Publicado: (1997)

Regional citrate anticoagulation with a low-concentration solution in predilution-postdilution CVVH
por: Pistolesi, V, et al.
Publicado: (2012)

Very high volume haemofiltration (VHVHF) (8.75 l/hour) sustained during a 4 hour period of time can remove by filtration significantly higher amounts of cytokine compared with low volume haemofiltration (LVHF) (1 l/hour) and is accompanied by a significant drop in cytokines only in haemodynamical responders and survivors during early severe septic shock
por: Honoré, PM, et al.
Publicado: (2003)

Citrate Anticoagulation for CRRT in Children: Comparison with Heparin
por: Fernández, Sara Nicole, et al.
Publicado: (2014)

Simplified Citrate Anticoagulation for CRRT Without Calcium Replacement
por: Broman, Marcus, et al.
Publicado: (2015)

CRRT influences PICCO measurements in febrile critically ill patients
por: Xu, Qiancheng, et al.
Publicado: (2022)

Experiences with Continuous Venovenous Hemofiltration using 18mmol/L predilution Citrate anticoagulation and a Phosphate Containing Replacement Solution
por: Jeffrey, Yuen Henry, et al.
Publicado: (2017)

Hepcidin is described as the master regulator of iron: could its removal by CRRT lead to iron dysmetabolism in the critically ill?
por: Honore, Patrick M., et al.
Publicado: (2020)

Citrate pharmacokinetics in critically ill liver failure patients receiving CRRT
por: Thanapongsatorn, Peerapat, et al.
Publicado: (2022)

Plasma-lyte(®) as dialysate for CRRT: institution of a new therapy and initial evaluation
por: McCunn, M, et al.
Publicado: (2002)

Preventing continuous renal replacement therapies (CRRT)-induced hypophosphatemia using a phosphate-containing CRRT solution in the setting of regional citrate anticoagulation
por: Pistolesi, V, et al.
Publicado: (2014)

Anidulafungin dosing during CRRT: do not underestimate adsorption!
por: Honore, Patrick M, et al.
Publicado: (2014)

Citrate anticoagulation for CRRT: don’t always trust the postfilter iCa results!
por: Oudemans-van Straaten, Heleen M., et al.
Publicado: (2015)

Bicarbonate buffered dialysate and replacement solutions for CRRT: effect of crystallization on the measured levels of electrolytes and buffer
por: Maccariello, E, et al.
Publicado: (2001)

Impact of CRRT in Patients with PARDS Treated with VV-ECMO
por: Redant, Sébastien, et al.
Publicado: (2021)

ECMO/CRRT combined support in the treatment of critically ill patients with novel coronavirus pneumonia
por: Zou, Hai, et al.
Publicado: (2020)

Early mortality on continuous renal replacement therapy (CRRT): the prairie CRRT study
por: Prasad, Bhanu, et al.
Publicado: (2016)

Clinical Trial Comparing the Efficacy and Safety of Regional Citrate Anticoagulation Versus Heparin in CRRT
por: Senthilkumar, S, et al.
Publicado: (2023)

Improving the quality of the performance and delivery of continuous renal replacement therapy (CRRT) to critically ill patients across a healthcare system: QUALITY CRRT: a study protocol
por: Opgenorth, Dawn, et al.
Publicado: (2022)

Intermittent high-volume predilution on-line haemofiltration versus standard intermittent haemodialysis in critically ill patients with acute kidney injury: a prospective randomized study
por: Škofic, Nataša, et al.
Publicado: (2012)

Continuous Renal Replacement Therapy (CRRT) for Nonrenal Indications among Critically Ill Children with Malignancy
por: Hui, Wun Fung, et al.
Publicado: (2021)

Comparison between meropenem and ceftolozane/tazobactam: possible influence of CRRT
por: Honore, Patrick M., et al.
Publicado: (2022)

ANTICOAGULATION, BLEEDING, AND IMMUNOTHROMBOSIS IN CRITICALLY ILL PATIENTS WITH COVID-19
por: PAEZ VARGAS, JUAN, et al.
Publicado: (2021)

Prophylactic anticoagulation with low dose enoxaparin: is the subcutaneous route appropriate in the critically ill?
por: Priglinger, U, et al.
Publicado: (2002)

Role of Fat-Free Mass Index on Amino Acid Loss during CRRT in Critically Ill Patients
por: Vicka, Vaidas, et al.
Publicado: (2023)

Timing and incidence density of upper gastrointestinal bleeding acquired by critically ill children
por: Chaïbou, M, et al.
Publicado: (2000)

Ionized calcium measurements during regional citrate anticoagulation in CRRT: we need better blood gas analyzers
por: Kindgen-Milles, Detlef, et al.
Publicado: (2015)

Endotoxemia, immunocompetence and the responsiveness of neutrophils in critically ill patients
por: Foster, DM, et al.
Publicado: (1997)

Continuous Renal Replacement Therapy (CRRT) in Children and the Specialized CRRT Team: A 14-Year Single-Center Study
por: Lee, Keum Hwa, et al.
Publicado: (2019)

Success rate of naso-jejunal tube placement influenced by CRRT: possible removal of metoclopramide
por: Honore, Patrick M., et al.
Publicado: (2021)

Anticoagulation strategies and risk of bleeding events in critically ill COVID-19 patients
por: Gabara, C., et al.
Publicado: (2023)

Anticoagulation strategies and risk of bleeding events in critically ill COVID-19 patients
por: Gabara, C., et al.
Publicado: (2023)

Quality indicators in continuous renal replacement therapy (CRRT) care in critically ill patients: protocol for a systematic review
por: Rewa, Oleksa, et al.
Publicado: (2015)

Discrepant post filter ionized calcium concentrations by common blood gas analyzers in CRRT using regional citrate anticoagulation
por: Schwarzer, Patrik, et al.
Publicado: (2015)

Citrate anticoagulation for continuous renal replacement therapy (CRRT) in patients with acute kidney injury admitted to the intensive care unit
por: Davenport, Andrew, et al.
Publicado: (2009)

Urine output before the initiation of CRRT and mortality
Publicado: (2013)

Prescription of CRRT: a pathway to optimize therapy
por: Karkar, Ayman, et al.
Publicado: (2020)

What metabolites are removed by CRRT except creatinine?
por: Li, Yue, et al.
Publicado: (2022)

Study claiming target in sepsis with erythromycin has no effect upon mortality and secondary outcomes includes patients with CRRT and RRT
por: Honore, Patrick M., et al.
Publicado: (2023)

Early restrictive fluid balance is associated with lower hospital mortality independent of acute disease severity in critically ill patients on CRRT
por: Uusalo, Panu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ms15vrqoro4vugqtj79lgpne8p